Advantages over single agonist: GIP appears to work synergistically with GLP-1 rather than additively, explaining the 6 percentage point improvement over Semaglutide
Medications in this category are now widely used in obesity medicine and metabolic care because they can lower appetite, improve insulin signaling, slow gastric emptying, and help patients reduce body fat over time
It doesn't need to fall back on compounded versions that might not be as safe or effective as brand-name drugs
It does not yet hold a marketing authorisation from the MHRA, and there is no approved Summary of Product Characteristics (SmPC)
Its affordable, tracks heart rate in real time, is water- and dust-resistant, and is compatible with over 200 apps and fitness platforms
The most effective results come from a layered approach combining injectables, skin tightening and collagen-stimulating treatments